Medi Futures

Medi Futures is a cutting-edge ultrasonic technology platform revolutionizing the field of biomedical technology with a focus on enzyme-free ultrasound stem cell separators and ultrasonic endoscopic disc surgical equipment. Founded in 2016, the company has gained prominence in the Health Care industry by providing innovative solutions that offer advanced ultrasonic and biological fusion medical technologies for both cosmetic and surgical applications.

Through these advancements, Medi Futures aims to facilitate minimal incision, reduce procedure time, and alleviate patient discomfort. The company's slogan ("Experience the future of ultrasonic medical technology for precision and minimal impact.") reflects its commitment to delivering state-of-the-art medical solutions that transform the way surgeries are conducted.

In a recent milestone, Medi Futures secured a significant KRW6.00B Series B investment on 06 August 2021 from DS Asset Management. This substantial investment is a testament to the confidence that investors have in the company's potential to drive meaningful innovation and make a tangible impact in the medical technology landscape. With this backing, Medi Futures is well-positioned to further develop its pioneering technologies and expand its market presence, potentially shaping the future of ultrasonic medical advancements.